Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern.

H J Dubbink1, R F Hoedemaeker, T H van der Kwast

  • 1Department of Urology, Josephine Nefkens Institute, Erasmus University, Rotterdam, The Netherlands. dubbink@path.fgg.eur.nl

Laboratory Investigation; a Journal of Technical Methods and Pathology
|March 6, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

End of a diagnostic odyssey: the added value of multi-tissue analysis in the identification of mosaicism in tumour predisposition syndromes.

Journal of medical genetics·2026
Same author

Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.

ESMO open·2024
Same author

Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report.

Familial cancer·2024
Same author

Recommendations on scuba diving in Birt-Hogg-Dubé syndrome.

Expert review of respiratory medicine·2023
Same author

Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.

ESMO open·2023

Human prostate-specific transglutaminase (hTGp) is a cross-linking enzyme. Its expression is exclusive to prostate luminal epithelial cells, with variable distribution and absent in prostate cancer.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Urology

Background:

  • Human prostate-specific transglutaminase (hTGp) is a cross-linking enzyme with an undetermined physiological role.
  • Understanding hTGp distribution is crucial for elucidating its function.

Purpose of the Study:

  • To investigate the tissue distribution and localization of human prostate-specific transglutaminase (hTGp).
  • To characterize the expression patterns of hTGp in normal and diseased prostate tissue.

Main Methods:

  • Raised antisera against hTGp for specific detection.
  • Utilized Western blotting to identify hTGp in biological samples.
  • Performed immunohistochemical analysis on prostatectomy specimens and biopsies.

Main Results:

Related Experiment Videos

  • hTGp is a 77-kDa protein found in prostatic fluids, seminal plasma, and tissues, with variable individual concentrations.
  • Expression is exclusively localized to luminal epithelial cells within the prostate.
  • Distinct expression patterns (scattered vs. clustered) were observed in different prostate zones.
  • hTGp was occasionally present in high-grade prostatic intraepithelial neoplasia but absent in prostate carcinoma.

Conclusions:

  • hTGp exhibits a unique expression pattern restricted to prostate luminal epithelial cells.
  • The observed distribution suggests a specialized role for hTGp within the prostate.
  • hTGp's absence in prostate cancer warrants further investigation into its potential as a biomarker.